AMRN — AMARIN CORP PLC\UK
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 897448 ·
Ireland
Last close
$11.99
Market Cap
$253.26M
52W High
$20.90
52W Low
$11.83
ADV30
58,609
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 42,211,000 | 14,989,000 | -11,970,000 | -7,650,000 | 624,363,000 | 143,558,000 | 180,747,000 |
| Mar 2026 | 45,132,000 | 17,769,000 | -8,011,000 | -10,512,000 | 645,764,000 | 131,063,000 | 196,351,000 |
| Dec 2025 | 49,219,000 | 23,169,000 | -2,261,000 | -1,224,000 | 670,775,000 | 134,660,000 | 211,494,000 |
| Sep 2025 | 49,670,000 | 22,208,000 | -1,697,000 | -7,738,000 | 659,814,000 | 122,802,000 | 200,920,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$15,573,000
Investing CF
$-17,805,000
Financing CF
$-2,186,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.40
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,725,506,000
Inventory
$164,073,000
Receivables
$92,917,000
ST Investments
$171,091,000
EBIT TTM
$-46,039,000
Pretax Income TTM
$-25,559,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$186,232,992
EBITDA
$-21,095,000
Free Cash Flow
$-5,569,250
Enterprise Value
$-15,978,891
Total Cash
$314,648,992
Total Debt
$7,175,000
Shares Out
21,122,834
Trailing EPS
$-1.20
Book Value
$21.12
ROE
-6.0%
ROA
-2.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 213,646,000 | -13,941,000 | -38,798,000 | 670,775,000 | 211,494,000 | 459,281,000 | 6,728,000 |
| Dec 2024 | 228,614,000 | -91,797,000 | -82,183,000 | 685,349,000 | 199,173,000 | 486,176,000 | -31,020,000 |
| Dec 2023 | 306,911,000 | -56,616,000 | -59,112,000 | 831,684,000 | 279,587,000 | 552,097,000 | 6,880,000 |
| Dec 2022 | 369,193,000 | -92,343,000 | -105,803,000 | 886,179,000 | 290,846,000 | 595,333,000 | -180,092,000 |
TTM Snapshot
Revenues TTM
$216,761,000
NetIncome TTM
$-33,613,000
OpCashFlow TTM
—
Assets (Latest)
$645,764,000
Forward EPS
$0.98
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACIU | AC Immune SA | $253.54M | $2.55 | — |
| PRLD | Prelude Therapeutics Inc | $252.49M | $3.88 | — |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | $252.43M | $0.15 | — |
| UPB | Upstream Bio, Inc. | $249.21M | $4.55 | — |
| VCRE | Vicore Pharma Holding AB | $248.41M | $8.82 | — |
News headlines (Yahoo Finance, 1h cache)
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
2026-09-09 19:54 · Yahoo
Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026
2026-08-24 14:10 · Yahoo
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
2026-08-24 12:15 · Yahoo
Amarin (AMRN) Q2 2026 Earnings Call Transcript
2026-08-08 01:28 · Yahoo
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
2026-10-09 16:55 · Yahoo
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
2026-10-09 14:53 · Yahoo
Viatris to Buy Pacira for $1.65B to Expand Non-Opioid Pain Portfolio
2026-10-09 13:37 · Yahoo
Here's Why You Should Add LPCN Stock to Your Portfolio Now
2026-10-08 13:57 · Yahoo
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
2026-10-07 15:08 · Yahoo
Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study
2026-10-01 12:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.